Patent Application
Utility
App. No. 14/629,176
· Confirmation No. 2385
MULTIDOSE PACKAGE, COURSE AND METHOD OF TREATMENT FOR DELIVERING PREDETERMINED MULTIPLE DOSES OF A PHARMACEUTICAL
Applicant:
BAUSCH HEALTH IRELAND LIMITED
Abandonment for Failure to Correct Drawings/Oath/NonPub Request
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2020-01-03 | PETDEC |
Petition Decision | 5 | View | |
| 2019-12-27 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2019-09-20 | PET.OP |
Petition for review by the Office of Petitions | 4 | View | |
| 2019-09-20 | PET.OP |
Petition for review by the Office of Petitions | 1 | View | |
| 2019-09-20 | R46C.REQ |
Request under 37CFR1.46(c) to correct, update, change applicant | 15 | View | |
| 2019-09-20 | ADS |
Application Data Sheet | 8 | View | |
| 2019-09-20 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2019-09-20 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2019-06-27 | ABN |
Abandonment | 1 | View | |
| 2019-06-24 | R46C.REQ |
Request under 37CFR1.46(c) to correct, update, change applicant | 9 | View | |
| 2019-06-24 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2019-06-24 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2019-06-24 | OATH |
Oath or Declaration filed | 3 | View | |
| 2019-06-24 | OATH |
Oath or Declaration filed | 3 | View | |
| 2019-06-24 | IFEE |
Issue Fee Payment (PTO-85B) | 1 | View | |
| 2019-06-24 | R3.73 |
Assignee showing of ownership per 37 CFR 3.73 | 2 | View | |
| 2019-06-24 | R46C.REQ |
Request under 37CFR1.46(c) to correct, update, change applicant | 1 | View | |
| 2019-06-24 | ADS |
Application Data Sheet | 7 | View | |
| 2019-03-27 | NOA |
Notice of Allowance and Fees Due (PTOL-85) | 9 | View | |
| 2019-03-27 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2019-03-27 | FWCLM |
Index of Claims | 1 | View | |
| 2019-03-27 | IIFW |
Issue Information including classification, examiner, name, claim, renumbering, etc. | 3 | View | |
| 2019-03-27 | 1449 |
List of References cited by applicant and considered by examiner | 1 | View | |
| 2019-03-27 | SRNT |
Examiner's search strategy and results | 9 | View | |
| 2019-03-27 | BIB |
Bibliographic Data Sheet | 1 | View | |
| 2019-02-22 | N271 |
Response to Amendment under Rule 312 | 2 | View | |
| 2019-02-21 | RCEX |
Request for Continued Examination (RCE) | 1 | View | |
| 2019-02-21 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2019-02-21 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 1 | View | |
| 2019-02-21 | FOR |
Foreign Reference | 17 | View | |
| 2019-02-21 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2019-02-21 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2019-02-19 | A.NA |
Amendment after Notice of Allowance (Rule 312) | 1 | View | |
| 2019-02-19 | SPEC |
Specification | 1 | View | |
| 2019-02-19 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2019-02-19 | LET. |
Miscellaneous Incoming Letter | 2 | View | |
| 2019-02-19 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2018-12-18 | M327 |
Miscellaneous Communication to Applicant - No Action Count | 3 | View | |
| 2018-12-11 | NOA |
Notice of Allowance and Fees Due (PTOL-85) | 2 | View | |
| 2018-11-21 | NOA |
Notice of Allowance and Fees Due (PTOL-85) | 6 | View | |
| 2018-11-21 | FWCLM |
Index of Claims | 1 | View | |
| 2018-11-21 | IIFW |
Issue Information including classification, examiner, name, claim, renumbering, etc. | 3 | View | |
| 2018-11-21 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2018-11-21 | BIB |
Bibliographic Data Sheet | 1 | View | |
| 2018-11-21 | SRNT |
Examiner's search strategy and results | 7 | View | |
| 2018-11-21 | SRNT |
Examiner's search strategy and results | 8 | View | |
| 2018-11-05 | A.QU |
Response after Ex Parte Quayle Action | 1 | View | |
| 2018-11-05 | CLM |
Claims | 4 | View | |
| 2018-11-05 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2018-11-05 | XT/ |
Extension of Time | 1 | View | |
| 2018-11-05 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2018-11-05 | 136A |
Authorization for Extension of Time all replies | 1 | View | |
| 2018-11-05 | SA.. |
Supplemental Response or Supplemental Amendment | 1 | View | |
| 2018-11-05 | CLM |
Claims | 4 | View | |
| 2018-11-05 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2018-11-05 | XT/ |
Extension of Time | 1 | View | |
| 2018-11-05 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2018-11-05 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2018-11-05 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2018-05-04 | CTEQ |
Ex Parte Quayle Action | 7 | View | |
| 2018-05-04 | FWCLM |
Index of Claims | 1 | View | |
| 2018-05-04 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2018-05-04 | SRNT |
Examiner's search strategy and results | 8 | View | |
| 2017-12-14 | DISQ |
Terminal Disclaimer review decision | 1 | View | |
| 2017-12-13 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2017-12-08 | RCEX |
Request for Continued Examination (RCE) | 3 | View | |
| 2017-12-08 | XT/ |
Extension of Time | 1 | View | |
| 2017-12-08 | AMSB |
Amendment Submitted/Entered with Filing of Continued Prosecution Application (CPA)/Request for Continued Examination(RCE) | 1 | View | |
| 2017-12-08 | CLM |
Claims | 4 | View | |
| 2017-12-08 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2017-12-08 | PA.. |
Power of Attorney | 1 | View | |
| 2017-12-08 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2017-12-08 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2017-12-08 | DIST |
Terminal Disclaimer Filed | 1 | View | |
| 2017-12-08 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2017-12-08 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2017-06-08 | CTFR |
Final Rejection | 23 | View | |
| 2017-06-08 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2017-06-08 | SRNT |
Examiner's search strategy and results | 8 | View | |
| 2017-06-08 | FWCLM |
Index of Claims | 1 | View | |
| 2017-04-07 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | 1 | View | |
| 2017-04-07 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2017-04-07 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2017-04-07 | XT/ |
Extension of Time | 1 | View | |
| 2017-04-07 | REM |
Applicant Arguments/Remarks Made in an Amendment | 4 | View | |
| 2017-04-07 | CLM |
Claims | 4 | View | |
| 2017-04-07 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2016-10-07 | CTNF |
Non-Final Rejection | 34 | View | |
| 2016-10-07 | 892 |
List of references cited by examiner | 1 | View | |
| 2016-10-07 | SRNT |
Examiner's search strategy and results | 6 | View | |
| 2016-10-07 | SRNT |
Examiner's search strategy and results | 5 | View | |
| 2016-10-07 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2016-10-07 | FWCLM |
Index of Claims | 1 | View | |
| 2016-06-21 | ELC. |
Response to Election / Restriction Filed | 1 | View | |
| 2016-06-21 | CLM |
Claims | 4 | View | |
| 2016-06-21 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2016-06-21 | XT/ |
Extension of Time | 1 | View | |
| 2016-06-21 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2016-06-21 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2016-06-21 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2015-12-21 | CTRS |
Requirement for Restriction/Election | 7 | View | |
| 2015-12-21 | FWCLM |
Index of Claims | 1 | View | |
| 2015-12-21 | 1449 |
List of References cited by applicant and considered by examiner | 2 | View | |
| 2015-06-25 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2015-06-15 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 2 | View | |
| 2015-06-15 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2015-06-15 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2015-03-16 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2015-03-16 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2015-03-16 | M327 |
Miscellaneous Communication to Applicant - No Action Count | 1 | View | |
| 2015-02-23 | ADS |
Application Data Sheet | 7 | View | |
| 2015-02-23 | SPEC |
Specification | 14 | View | |
| 2015-02-23 | CLM |
Claims | 3 | View | |
| 2015-02-23 | ABST |
Abstract | 1 | View | |
| 2015-02-23 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2015-02-23 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View |
Inventors
Mark J. Hutchings
Thornleigh, AUSTRALIA
Christiaan M. Van Niekerk
Thornleigh, AUSTRALIA
Attorneys & Agents of Record
Classification
USPC
514/293
A61K31/4745
A61P17/00
A61P17/02
A61P15/00
A61J1/00
A61K9/0014
A61K9/06
A61K31/437
B65B3/04
Prosecution
- Examiner
- TRAN, MY CHAU T
- Art Unit
- 1629
- Customer No.
- 112120
- Docket No.
- 92785-007620US-927952
- Confirmation No.
- 2385
Foreign Priority
2009901410
·
2009-04-01
·
AUSTRALIA
Publication
- Pub. No.
- US20150174120A1
- Pub. Date
- 2015-06-25
Parent
is a Division of
→
App. 13/262,782
· US 8,962,649
Filed 2011-12-30
· Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362
Parent
PCT
is a National Stage Entry of
→
PCT/AU2010/000372
Filed 2010-04-01
· Abandonment for Failure to Correct Drawings/Oath/NonPub Request
Child
is a Continuation of
→
App. 16/280,600
· US 11,077,102
Filed 2019-02-20
· Patented Case
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, LTD.,
SALIX PHARMACEUTICALS, INC.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS IRELAND LIMITED
RELEASE OF SECURITY INTEREST
Recorded 2025-11-20
BAUSCH HEALTH IRELAND LIMITED,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH, CANADA INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMA POLAND SPOLKA Z ORGANICZONA ODPOWIEDZIALNOSCIA,
VALEANT SP. Z.O.O.
RELEASE OF SECURITY INTEREST
Recorded 2025-11-20
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
from
BAUSCH & LOMB IRELAND LIMITED,
BAUSCH HEALTH COMPANIES INC.,
DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH,
TECHNOLAS PERFECT VISION GMBH
SECURITY INTEREST
Recorded 2021-10-05
from
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH IRELAND LIMITED,
BAUSCH HEALTH, CANADA INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA,
VALEANT PHARMACEUTICALS LUXEMBOURG S.À R.L.,
VALEANT SP. Z O. O.
INTELLECTUAL PROPERTY SECURITY AGREEMENT
Recorded 2019-07-03
from
WIRRA IP PTY LIMITED
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2018-12-19
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2018-07-02
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND LIMITED,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED
SECURITY INTEREST
Recorded 2018-02-26
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND LIMITED,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED
SECURITY INTEREST
Recorded 2018-02-26
SECURITY INTEREST
Recorded 2017-07-19
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSH & LOMB PHARMA HOLDINGS CORP.,
DENDREON PHARMACEUTICALS, INC.,
DOW PHARMACEUTICAL SCIENCES, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
OBAGI MEDICAL PRODUCTS, INC.,
OMP, INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
VALEANT CANADA LP, BY ITS GENERAL PARTNER VALEANT CANADA GP LIMITED,
VALEANT HOLDINGS IRELAND (AS SUCCESSOR TO VALEANT INTERNATIONAL BERMUDA),
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC
SECURITY INTEREST
Recorded 2016-07-18
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 14/629,176
- Filed
- 2015-02-23
- Pub. No.
- US20150174120A1
- Examiner
- TRAN, MY CHAU T
- Art Unit
- 1629
External Links